$Ino News out!
INOVIO and
@IVIHeadquarters
in partnership with Seoul National University Hospital dosed the first patient in a Phase 1/2 clinical trial of INOVIO's #COVID19 DNA vaccine candidate in South Korea. #DNAVaccines #DNAMedicines
My picks are Just in My Opinion, Im no Broker, and its all based on Charts, Due Diligence is needed before Investing in any pick.!